Use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failure
The aim of this study was to use indicators to evaluate physician adherence to prescription guidelines for heart failure treatment in a university hospital. This was a prospective cohort study conducted in a university hospital. The information collected at the time of patient admission, including t...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade de São Paulo
2013-12-01
|
| Series: | Brazilian Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000400023&lng=en&tlng=en |
| _version_ | 1811329685036990464 |
|---|---|
| author | Márcio Galvão Oliveira Luiz Carlos Passos Edval Gomes Santos Júnior Andrea Cristina Barbosa Djanilson Barbosa Santos |
| author_facet | Márcio Galvão Oliveira Luiz Carlos Passos Edval Gomes Santos Júnior Andrea Cristina Barbosa Djanilson Barbosa Santos |
| author_sort | Márcio Galvão Oliveira |
| collection | DOAJ |
| description | The aim of this study was to use indicators to evaluate physician adherence to prescription guidelines for heart failure treatment in a university hospital. This was a prospective cohort study conducted in a university hospital. The information collected at the time of patient admission, including therapeutic indication, absolute contra indications and intolerance, was utilised for the formulation of a guideline adherence indicator (GAI). This indicator was calculated as follows: (the number of patients who used the medication/the number of eligible patients) x 100. The percentage of eligible patients was calculated using the following formula: (the number of eligible patients/the total number patients) x 100. The GAI was applied to a population of 53 patients. Inhibitors of angiotensin-converting enzyme/angiotensin receptor blocker (ACE-I/ARB) combination therapy were used in the greatest percentage of eligible patients (92.4%) and demonstrated the largest GAI value (73.5%). The percentages of patients who were eligible for beta-blockers, spironolactone and digitalis treatments were 81.1%, 52.8% and 60.4%, respectively. The GAI values for the use of beta-blockers, spironolactone and digitalis were 60.4%, 57.1% and 56.2%, respectively. For the studied patient population, the GAI was consistent with the proportion of patients who were eligible to receive digitalis and spironolactone. |
| first_indexed | 2024-04-13T15:48:11Z |
| format | Article |
| id | doaj.art-030f1e1a5af5439eb11ccd75e83c204b |
| institution | Directory Open Access Journal |
| issn | 2175-9790 |
| language | English |
| last_indexed | 2024-04-13T15:48:11Z |
| publishDate | 2013-12-01 |
| publisher | Universidade de São Paulo |
| record_format | Article |
| series | Brazilian Journal of Pharmaceutical Sciences |
| spelling | doaj.art-030f1e1a5af5439eb11ccd75e83c204b2022-12-22T02:40:55ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902013-12-0149483183610.1590/S1984-82502013000400023S1984-82502013000400023Use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failureMárcio Galvão Oliveira0Luiz Carlos Passos1Edval Gomes Santos Júnior2Andrea Cristina Barbosa3Djanilson Barbosa Santos4Universidade Federal da BahiaUniversidade Federal da BahiaUniversidade Federal da BahiaUniversidade Federal da BahiaUniversidade Federal do Recôncavo da BahiaThe aim of this study was to use indicators to evaluate physician adherence to prescription guidelines for heart failure treatment in a university hospital. This was a prospective cohort study conducted in a university hospital. The information collected at the time of patient admission, including therapeutic indication, absolute contra indications and intolerance, was utilised for the formulation of a guideline adherence indicator (GAI). This indicator was calculated as follows: (the number of patients who used the medication/the number of eligible patients) x 100. The percentage of eligible patients was calculated using the following formula: (the number of eligible patients/the total number patients) x 100. The GAI was applied to a population of 53 patients. Inhibitors of angiotensin-converting enzyme/angiotensin receptor blocker (ACE-I/ARB) combination therapy were used in the greatest percentage of eligible patients (92.4%) and demonstrated the largest GAI value (73.5%). The percentages of patients who were eligible for beta-blockers, spironolactone and digitalis treatments were 81.1%, 52.8% and 60.4%, respectively. The GAI values for the use of beta-blockers, spironolactone and digitalis were 60.4%, 57.1% and 56.2%, respectively. For the studied patient population, the GAI was consistent with the proportion of patients who were eligible to receive digitalis and spironolactone.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000400023&lng=en&tlng=enInsuficiência cardíacaAssistência à SaúdeClinica médicaMedicamentosMedicamentos |
| spellingShingle | Márcio Galvão Oliveira Luiz Carlos Passos Edval Gomes Santos Júnior Andrea Cristina Barbosa Djanilson Barbosa Santos Use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failure Brazilian Journal of Pharmaceutical Sciences Insuficiência cardíaca Assistência à Saúde Clinica médica Medicamentos Medicamentos |
| title | Use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failure |
| title_full | Use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failure |
| title_fullStr | Use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failure |
| title_full_unstemmed | Use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failure |
| title_short | Use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failure |
| title_sort | use of an indicator to evaluate physician adherence to prescription guidelines for the treatment of heart failure |
| topic | Insuficiência cardíaca Assistência à Saúde Clinica médica Medicamentos Medicamentos |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000400023&lng=en&tlng=en |
| work_keys_str_mv | AT marciogalvaooliveira useofanindicatortoevaluatephysicianadherencetoprescriptionguidelinesforthetreatmentofheartfailure AT luizcarlospassos useofanindicatortoevaluatephysicianadherencetoprescriptionguidelinesforthetreatmentofheartfailure AT edvalgomessantosjunior useofanindicatortoevaluatephysicianadherencetoprescriptionguidelinesforthetreatmentofheartfailure AT andreacristinabarbosa useofanindicatortoevaluatephysicianadherencetoprescriptionguidelinesforthetreatmentofheartfailure AT djanilsonbarbosasantos useofanindicatortoevaluatephysicianadherencetoprescriptionguidelinesforthetreatmentofheartfailure |